articleTop 10% cited
The Value of Serum CA 19-9 in Predicting Cholangiocarcinomas in Patients with Primary Sclerosing Cholangitis
Digestive Diseases and Sciences · 2005 · Vol. 50(9) · pp. 1734–1740
Cynthia Levy✉(University of Florida)James Lymp(Mayo Clinic)Paul Angulo(Mayo Clinic)Gregory J. Gores(University of Florida)Nicholas F. LaRusso(WinnMed)Keith D. Lindor(University of Florida)
Cholangiocarcinoma and Gallbladder Cancer StudiesGallbladder and Bile Duct DisordersLiver Diseases and ImmunityPrimary sclerosing cholangitisMedicineHepatologyPredictive valueGastroenterologyInternal medicineCutoffTransplant surgeryPredictive value of tests
MeSH terms
Bile Duct NeoplasmsFemaleHumansMaleMiddle AgedPredictive Value of TestsReference ValuesCholangitis, SclerosingCholangiocarcinomaCA-19-9 Antigen
Funding
- Mayo Clinic
- NIH Clinical Center
Citations
335
FWCI
10.42
field-weighted impact
References
23
Percentile
99%
vs. same field & year
Citations per year
Cited by
Diagnosis and Management of Primary Sclerosing Cholangitis
Hepatology · 2009 · 1,214 citations
Related articles
Understanding diagnostic tests 1: sensitivity, specificity and predictive values
Acta Paediatrica · 2007 · 696 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.